FECAL CALPROTECTIN - A NOVEL TEST FOR THE DIAGNOSIS OF COLORECTAL-CANCER

被引：129
|
作者：
ROSETH, AG
KRISTINSSON, J
FAGERHOL, MK
SCHJONSBY, H
AADLAND, E
NYGAARD, K
ROALD, B
机构：
[1] AKER UNIV HOSP,DEPT SURG,N-0514 OSLO,NORWAY
[2] ULLEVAL UNIV HOSP,BLOOD BANK,OSLO,NORWAY
[3] ULLEVAL UNIV HOSP,DEPT PATHOL,OSLO,NORWAY
[4] ULLEVAL UNIV HOSP,DEPT IMMUNOL,OSLO,NORWAY
来源：
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1993年 / 28卷 / 12期
关键词：
COLORECTAL ADENOMAS; COLORECTAL CANCER; FECAL CALPROTECTIN; GASTRIC CANCER;
D O I：
10.3109/00365529309098312
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Calprotectin, a prominent cytosol protein in neutrophil granulocytes, was present in increased concentrations in stools from 50 of 53 patients with colorectal cancer, 32 of 40 patients with colorectal polyps, and all of 18 patients with gastric cancer. After radical surgery, faecal calprotectin levels reverted to the normal range in all but one patient with colorectal cancer. Calprotectin determinations are simplified by the stability of this protein in stools. Reliable estimates can be obtained in samples of only 5 g. On the basis of data from the literature, the test for calprotectin seems better than that for occult blood for the detection of gastrointestinal neoplasms.
引用
收藏
页码：1073 / 1076
页数：4
相关论文
共 50 条
  • [1] How useful is fecal calprotectin for the diagnosis of IBD and colorectal cancer?
    Lashner, Bret A.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (01): : 16 - 17
  • [2] The Role of Fecal Calprotectin and Fecal Immunochemical Test for Neoplastic Lesion of Colorectal in Indonesian Population
    Utari, Amanda Pitarini
    Abdullah, Murdani
    DIGESTION, 2021, 102 (01) : 101 - 101
  • [3] CLINICOPATHOLOGICAL STUDIES OF IMMUNOLOGICAL FECAL OCCULT BLOOD-TEST FOR COLORECTAL-CANCER
    IIDA, Y
    MUNEMOTO, Y
    MIURA, S
    KASAHARA, Y
    SAITO, H
    MITSUI, T
    ASADA, Y
    FUKUOKA, K
    TOYA, D
    TANAKA, N
    KIMURA, A
    FUJISAWA, M
    JOURNAL OF GASTROENTEROLOGY, 1995, 30 (02) : 195 - 200
  • [4] INTERVAL CANCERS IN SCREENING WITH FECAL OCCULT BLOOD-TEST FOR COLORECTAL-CANCER
    JENSEN, BM
    KRONBORG, O
    FENGER, C
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (09) : 779 - 782
  • [5] COLORECTAL-CANCER SCREENING - OPTIMAL COMPLIANCE WITH POSTAL FECAL OCCULT BLOOD-TEST
    KING, J
    FAIRBROTHER, G
    THOMPSON, C
    MORRIS, DL
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1992, 62 (09): : 714 - 719
  • [6] Fecal excretion of calprotectin in colorectal cancer - Relationship to tumor characteristics
    Kristinsson, J
    Armbruster, C
    Ugstad, M
    Kriwanek, S
    Nygaard, K
    Ton, H
    Fuglerud, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (02) : 202 - 207
  • [7] ENDOSCOPY IN COLORECTAL-CANCER
    MCLEISH, A
    DIAGNOSTIC ONCOLOGY, 1994, 4 (2-3): : 105 - 111
  • [8] Fecal calprotectin concentration in patients with colorectal carcinoma
    Kristinsson, J
    Roseth, A
    Fagerhol, MK
    Aadland, E
    Schjonsby, H
    Bormer, OP
    Raknerud, N
    Nygaard, K
    DISEASES OF THE COLON & RECTUM, 1998, 41 (03) : 316 - 321
  • [9] A new fecal calprotectin test for colorectal neoplasia - Clinical results and comparison with previous method
    Johne, B
    Kronborg, O
    Ton, HI
    Kristinsson, J
    Fuglerud, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (03) : 291 - 296
  • [10] COLORECTAL-CANCER
    BINGHAM, S
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1993, 5 (08) : 574 - 577
12345